Published in Scand J Urol Nephrol on January 01, 2005
Inducible nitric oxide synthase modulates hydronephrosis following partial or complete unilateral ureteral obstruction in the neonatal mouse. Am J Physiol Renal Physiol (2009) 0.84
Altered Nitric Oxide System in Cardiovascular and Renal Diseases. Chonnam Med J (2016) 0.79
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial. Ann Intern Med (2013) 2.84
Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol (2008) 2.31
Treatment of chronic hepatitis C in Asia: when East meets West. J Gastroenterol Hepatol (2009) 2.23
Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? J Urol (2010) 2.16
Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol (2010) 2.02
Low exposure to melamine increases the risk of urolithiasis in adults. Kidney Int (2011) 1.98
Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc Natl Acad Sci U S A (2007) 1.93
Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J Hepatol (2008) 1.82
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology (2008) 1.81
Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients. Hepatology (2011) 1.68
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc Natl Acad Sci U S A (2008) 1.65
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial. Hepatology (2008) 1.64
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy. Hepatology (2006) 1.62
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C. Gut (2006) 1.59
Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan. J Gastroenterol Hepatol (2007) 1.58
Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection. Am J Gastroenterol (2008) 1.54
Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response. J Gastroenterol Hepatol (2010) 1.54
Laparoscopic complete urinary tract exenteration with the specimen withdrawn transvaginally. BJU Int (2009) 1.52
Green tea catechins decrease oxidative stress in surgical menopause-induced overactive bladder in a rat model. BJU Int (2012) 1.49
A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Antivir Ther (2006) 1.48
Extra-adrenal pheochromocytoma presenting with life-threatening ventricular tachycardia: a case report. Kaohsiung J Med Sci (2004) 1.45
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype. J Clin Virol (2013) 1.45
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3. Gastroenterology (2010) 1.38
Incidence and clinical outcome of icteric type hepatocellular carcinoma. J Gastroenterol Hepatol (2002) 1.38
Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gastroenterol Hepatol (2007) 1.36
Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C. J Infect Dis (2010) 1.34
The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Liver Int (2011) 1.33
Long-term results of total condylar knee arthroplasty. J Arthroplasty (2005) 1.21
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin. J Hepatol (2011) 1.18
The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol (2009) 1.16
Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease. Clin Chim Acta (2010) 1.13
Interactive effects of lifetime alcohol consumption and alcohol and aldehyde dehydrogenase polymorphisms on esophageal cancer risks. Int J Cancer (2006) 1.13
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients. J Hepatol (2009) 1.13
Renal cell carcinoma presenting with skull metastasis: a case report and literature review. Kaohsiung J Med Sci (2007) 1.13
Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy. Clin Cancer Res (2010) 1.13
Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet (2003) 1.11
Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am J Gastroenterol (2007) 1.10
Paraganglioma of the urinary bladder first presented by bladder bloody tamponade: two case reports and review of the literatures. Kaohsiung J Med Sci (2011) 1.10
The role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and C. Gut (2007) 1.10
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection. J Infect Dis (2005) 1.09
p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.08
Association between response to pegylated interferon/ribavirin therapy and ribavirin levels. Hepatology (2014) 1.08
The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies. Gut (2007) 1.08
Variants of the inosine triphosphate pyrophosphatase gene and relapse risk following treatment for HCV genotype 2/3. Hepatology (2014) 1.07
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection. Gastroenterology (2010) 1.07
A 24-week pegylated interferon alpha-2b versus a 12-week pegylated interferon alpha-2b alone or with ribavirin for patients with acute hepatitis C. Hepatology (2014) 1.05
Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells. Biomed Pharmacother (2012) 1.04
Viral hepatitis infections in southern Taiwan: a multicenter community-based study. Kaohsiung J Med Sci (2010) 1.02
Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma. Hepatogastroenterology (2004) 1.02
Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1. Antiviral Res (2011) 1.00
Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine. Urol Oncol (2009) 1.00
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3. Gut (2011) 1.00
Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy. Prostate (2011) 1.00
Association of body mass index and urine pH in patients with urolithiasis. Urol Res (2009) 0.99
A ring-shaped stone in a female urethral diverticulum: case report and review of literature. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.99
A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan. Liver Int (2006) 0.98
Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan. J Hepatol (2009) 0.98
Local factors compared with systemic factors in the formation of bladder uric acid stones. Urol Int (2009) 0.97
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion. Hepatology (2013) 0.97
Acute necrotizing ureteritis with obstructive uropathy following instillation of silver nitrate in chyluria: a case report. Kaohsiung J Med Sci (2004) 0.97
Comparison of percutaneous nephrolithotomy and ureteroscopic lithotripsy in the management of impacted, large, proximal ureteral stones. Kaohsiung J Med Sci (2008) 0.96
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology (2013) 0.96
Impact of lower pole anatomy on stone clearance after shock wave lithotripsy. Kaohsiung J Med Sci (2005) 0.96
Supraumbilical skin rash and fat necrosis after transcatheter arterial chemoembolization: a case report. Kaohsiung J Med Sci (2004) 0.95
Intra- and extra-abdominal actinomycosis mimicking urachal tumor in an intrauterine device carrier: a case report. Kaohsiung J Med Sci (2008) 0.95
Xanthogranulomatous prostatitis: a rare entity resembling prostate adenocarcinoma with magnetic resonance image picture. Clin Imaging (2012) 0.95
Giant extrarenal retroperitoneal angiomyolipoma: a case report and literature review. Kaohsiung J Med Sci (2003) 0.94
The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin Chim Acta (2010) 0.94
The prevalence of and risk factors for androgen deficiency in aging Taiwanese men. J Sex Med (2008) 0.94
Comparison of laparoscopic adrenalectomy with open surgery for adrenal tumors. Kaohsiung J Med Sci (2009) 0.94
Mutation of the p53 tumor suppressor gene in transitional cell carcinoma of the urinary tract in Taiwan. Kaohsiung J Med Sci (2005) 0.93
The impact of cigarette smoking, alcohol drinking and betel quid chewing on the risk of calcium urolithiasis. Ann Epidemiol (2009) 0.93
KMUP-1 relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: involvement of cyclic GMP and K(+) channels. Br J Pharmacol (2002) 0.93
Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer. J Urol (2003) 0.93
Chronic hepatitis C infection is associated with insulin resistance and lipid profiles. J Gastroenterol Hepatol (2015) 0.92
Etiology, severity and recurrence of acute pancreatitis in southern taiwan. J Formos Med Assoc (2006) 0.92
Clinical outcome of Taiwanese men with metastatic prostate cancer compared with other ethnic groups. Urology (2008) 0.92
Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection. J Infect Dis (2003) 0.92
Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma. J Biomed Sci (2009) 0.92
Colon perforation: a rare complication during percutaneous nephrolithotomy. Kaohsiung J Med Sci (2006) 0.92
Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization. Kaohsiung J Med Sci (2011) 0.91
Spontaneous perirenal hematoma: a case report. Kaohsiung J Med Sci (2005) 0.91
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy. Int J Cancer (2011) 0.91
Management of symptomatic urolithiasis during pregnancy. Kaohsiung J Med Sci (2007) 0.91
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. J Infect Dis (2010) 0.90
Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C. Transl Res (2006) 0.90
SRD5A polymorphisms and biochemical failure after radical prostatectomy. Eur Urol (2011) 0.90
Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy. Ann Surg Oncol (2013) 0.90
Deletions of the androgen-metabolizing UGT2B genes have an effect on circulating steroid levels and biochemical recurrence after radical prostatectomy in localized prostate cancer. J Clin Endocrinol Metab (2011) 0.90
Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan. Jpn J Infect Dis (2007) 0.89